Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELITE: Levetiracetam Extended-Release + Stupp Protocol for IDH-Wildtype Glioblastoma
NCT07758062Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in glioblastoma (GBM), sponsored by Tianjin Medical University General Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07758062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758062.